| abstract |
The present invention is directed to a human or animal patient by delivering a therapeutically effective amount of a compound selected from the group consisting of urea, urea derivatives, thiourea, thiourea derivatives, guanidines, guanidine derivatives, and compounds having Formula I as provided herein A method of treating eye diseases and / or neurological diseases. For application to the eye, the compounds can be delivered by intravitreal injection to cause vitreous liquefaction, posterior vitreous retinal detachment and other effects. |